{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:38:29Z","timestamp":1782805109468,"version":"3.54.5"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Polidocanol is a safe sclerosing agent with anesthetic properties and minimal skin toxicity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To evaluate the efficacy, safety, and recurrence rates with polidocanol sclerotherapy in the treatment of pyogenic granulomas (PGs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS AND METHODS<\/jats:title>\n            <jats:p>Thirty-nine patients with PG were injected with polidocanol 1% solution. Repeat injections were given weekly in case of incomplete clinical\/dermoscopic resolution, until a maximum of 3 sittings. A higher strength (3%) was used for subsequent sessions in those with a minimal response to 1% solution. A final assessment for relapses was performed at 3, 6, and 12 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>All 39 patients achieved complete resolution (100% clearance rate), with most (<jats:italic toggle=\"yes\">n<\/jats:italic> = 26) lesions resolving after the first sitting. Side effects noted were postprocedure pain (22), erythema (2), superficial ulceration (2), paresthesias (1), prominent edema (4), thrombophlebitis (1), cyanotic discoloration (1), purpuric staining around injection site (4), and mild local pruritus (1). The procedure was well tolerated across the age spectrum (4\u201363 years) included.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>We report polidocanol to be a highly effective, safe, and cost-effective sclerosant for treatment of PGs with no recurrences or need for special postprocedure care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000003308","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T09:00:57Z","timestamp":1637744457000},"page":"72-75","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Polidocanol Sclerotherapy in Pyogenic Granulomas"],"prefix":"10.1097","volume":"48","author":[{"given":"Ananta","family":"Khurana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinu Rose","family":"Mathachan","sequence":"additional","affiliation":[{"name":"Both authors are affiliated with the Department of Dermatology, Dr. Ram Manohar Lohia Hospital and ABVIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/ijd.14268","article-title":"Therapeutic approaches to pyogenic granuloma: an updated review","volume":"58","author":"Plachouri","year":"2019","journal-title":"Int J Dermatol"},{"key":"R2-20250731","first-page":"521","article-title":"Treatment of pyogenic granuloma with a sclerosing agent","volume":"27","author":"Matsumoto","year":"2001","journal-title":"Dermatol Surg"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/archderm.141.5.644","article-title":"Treatment of pyogenic granuloma by sodium tetradecyl sulfate sclerotherapy","volume":"141","author":"Moon","year":"2005","journal-title":"Arch Dermatol"},{"issue":"Suppl 2","key":"R4-20250731","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1524-4725.2009.01470.x","article-title":"Letter: polidocanol sclerotherapy for the treatment of pyogenic granuloma","volume":"36","author":"Carvalho","year":"2010","journal-title":"Dermatol Surg"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1016\/j.bjps.2009.07.002","article-title":"Complete resolution of a recurrent giant pyogenic granuloma on the palm of the hand following single dose of intralesional bleomycin injection","volume":"63","author":"Daya","year":"2010","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R6-20250731","first-page":"852","article-title":"Sclerotherapy of hemangiomas and vascular malformations in lips","volume":"16","author":"Kawanabe","year":"1996","journal-title":"J Jpn P R S"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/1574884713666180223121828","article-title":"An evidence-based review of off-label uses of polidocanol","volume":"12","author":"Ebrahimi","year":"2017","journal-title":"Curr Clin Pharmacol"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bjps.2010.12.021","article-title":"Treatment options for cutaneous pyogenic granulomas: a review","volume":"64","author":"Lee","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.bjps.2006.10.018","article-title":"Pyogenic granuloma - the quest for optimum treatment: audit of treatment of 408 cases","volume":"60","author":"Giblin","year":"2007","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7181\/acfs.2017.18.1.16","article-title":"Pyogenic granuloma: a retrospective analysis of cases treated over a 10-year","volume":"18","author":"Koo","year":"2017","journal-title":"Arch Craniofac Surg"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1525-1470.1991.tb00931.x","article-title":"Pyogenic granuloma (lobular capillary hemangioma): a clinicopathological study of 178 cases","volume":"8","author":"Patrice","year":"1991","journal-title":"Pediatr Dermatol"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/jhsu.2003.50092","article-title":"The efficacy of silver nitrate cauterization for pyogenic granuloma of the hand","volume":"28","author":"Quitkin","year":"2003","journal-title":"J Hand Surg Am"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"e15024","DOI":"10.1111\/dth.15024","article-title":"Efficacy of bleomycin as a treatment modality in pyogenic granuloma: a case series","volume":"34","author":"Khurana","year":"2021","journal-title":"Dermatol Ther"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/0268355513483280","article-title":"European guidelines for sclerotherapy in chronic venous disorders","volume":"29","author":"Rabe","year":"2014","journal-title":"Phlebology"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jvsv.2017.03.017","article-title":"Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations","volume":"5","author":"Yamaki","year":"2017","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.2169\/internalmedicine.4327-19","article-title":"Successful endoscopic sclerotherapy using polidocanol for small bowel hemangioma","volume":"59","author":"Aoyama","year":"2020","journal-title":"Intern Med"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/jop.12764","article-title":"The efficacy of polidocanol sclerotherapy in mucocele of the minor salivary gland","volume":"47","author":"Liu","year":"2018","journal-title":"J Oral Pathol Med"},{"issue":"Suppl 2","key":"R18-20250731","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1524-4725.2009.01469.x","article-title":"Sclerosants: a comparative review","volume":"36","author":"Duffy","year":"2010","journal-title":"Dermatol Surg"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1524-4725.1995.tb00184.x","article-title":"The Australian polidocanol (aethoxysklerol) study","volume":"21","author":"Conrad","year":"1995","journal-title":"Dermatol Surg"},{"key":"R20-20250731","first-page":"52","article-title":"Treatment of varicose and telangiectatic leg veins: double blind prospective comparative trial between aethoxysklerol and sotradecol","volume":"28","author":"Goldman","year":"2002","journal-title":"Dermatol Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:10:47Z","timestamp":1753999847000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000003308","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]}}}